Section Arrow
NARI.NASDAQ
- Inari Medical
Quotes are at least 15-min delayed:2024/05/15 18:42 EDT
Last
 46.99
+1.49 (+3.27%)
Day High 
47.31 
Prev. Close
45.5 
1-M High
46.95 
Volume 
815.56K 
Bid
46
Ask
47.15
Day Low
45.88 
Open
45.88 
1-M Low
36.73 
Market Cap 
2.65B 
Currency USD 
P/E -- 
%Yield
10-SMA 42.94 
20-SMA 40.52 
50-SMA 42.07 
52-W High 71.85 
52-W Low 36.73 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.41/0.09
Enterprise Value
2.68B
Balance Sheet
Book Value Per Share
7.69
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
493.63M
Operating Revenue Per Share
8.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.1276+0.0726+132.00%-- 
CATXPerspective Therapeutics1.57-0.19-10.80%-- 
PACBPacific Biosciences of California2.145-0.085-3.81%-- 
ZOMZomedica Corp0.1692+0.0231+15.81%-- 
AEMDAethlon Medical0.4-0.4501-52.95%-- 
Quotes are at least 15-min delayed:2024/05/15 18:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the companygenerates majority of its revenue from United States and rest from International markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.